Home Institutions Moffitt Cancer Center clinical trials Institution Directory
Clinical trials at Moffitt Cancer Center Sites in Tampa, FL
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Nov 2, 2026, 11:40 AM EST
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
710
Current sort
Recently updated
Campus scope
Moffitt Cancer Center, Tampa, FL
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 625–636 of 710 matching trials with a site at Moffitt Cancer Center, Tampa, FL.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm
Interventions Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Ustekinumab Drug · Other · Biological
Lead sponsor Fred Hutchinson Cancer Center Other
Eligibility 18 Years to 70 Years
Enrollment 116 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2027
U.S. locations 4
States / cities Duarte, California • Tampa, Florida • Buffalo, New York + 1 more
Conditions Prostate Cancer
Interventions Radiation Therapy, Enzalutamide, Bicalutamide, GnRH analog Radiation · Drug
Lead sponsor RTOG Foundation, Inc. Other
Eligibility 18 Years and older · Male only
Enrollment 188 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2019 – 2029
U.S. locations 106
States / cities Gilbert, Arizona • Peoria, Arizona • Phoenix, Arizona + 89 more
Conditions Low Grade Serous Carcinoma
Interventions Ribociclib, Letrozole Drug
Lead sponsor Gynecologic Oncology Group Network
Eligibility 18 Years and older · Female only
Enrollment 51 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2019 – 2026
U.S. locations 27
States / cities San Francisco, California • Gainesville, Florida • Tampa, Florida + 19 more
Conditions Myelodysplastic Syndromes
Interventions SX-682, Decitabine Drug
Lead sponsor Syntrix Biosystems, Inc. Industry
Eligibility 18 Years and older
Enrollment 151 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2029
U.S. locations 7
States / cities Jacksonville, Florida • Miami, Florida • Orlando, Florida + 4 more
Conditions ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Interventions Clinical Observation, Crizotinib, Laboratory Biomarker Analysis Other · Drug
Lead sponsor ECOG-ACRIN Cancer Research Group Network
Eligibility 18 Years and older
Enrollment 166 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2015 – 2036
U.S. locations 1613
States / cities Birmingham, Alabama • Daphne, Alabama • Mobile, Alabama + 978 more
Conditions Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Interventions Bosutinib, Dasatinib, Laboratory Biomarker Analysis, Nilotinib, Ruxolitinib, Imatinib Drug · Other
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 81 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2028
U.S. locations 541
States / cities Anchorage, Alaska • Fairbanks, Alaska • Kingman, Arizona + 320 more
Conditions Metastatic Urothelial Carcinoma
Interventions Ipilimumab, Nivolumab, Sacituzumab govitecan Drug
Lead sponsor H. Lee Moffitt Cancer Center and Research Institute Other
Eligibility 18 Years and older
Enrollment 46 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2027
U.S. locations 1
States / cities Tampa, Florida
Conditions Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
Interventions Daromun, Surgery, Adjuvant therapy Drug · Procedure
Lead sponsor Philogen S.p.A. Industry
Eligibility 18 Years and older
Enrollment 186 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2031
U.S. locations 19
States / cities Phoenix, Arizona • La Jolla, California • Orange, California + 16 more
Conditions GIST
Interventions Ripretinib, Sunitinib Drug
Lead sponsor Deciphera Pharmaceuticals, LLC Industry
Eligibility 18 Years and older
Enrollment 54 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2028
U.S. locations 20
States / cities La Jolla, California • New Haven, Connecticut • Jacksonville, Florida + 15 more
Conditions Acute Myeloid Leukemia, in Relapse, MDS
Interventions MT-401-OTS Drug
Lead sponsor Marker Therapeutics, Inc. Industry
Eligibility 65 Years and older
Enrollment 40 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 3
States / cities Duarte, California • Tampa, Florida • Kansas City, Kansas
Conditions Chronic Graft-Versus-Host Disease (cGVHD)
Interventions Vimseltinib Drug
Lead sponsor Deciphera Pharmaceuticals, LLC Industry
Eligibility 18 Years and older
Enrollment 48 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 26
States / cities Duarte, California • Los Angeles, California • Orange, California + 22 more
Conditions Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8, Stage II Pancreatic Neuroendocrine Tumor AJCC v8, Stage III Pancreatic Neuroendocrine Tumor AJCC v8
Interventions Capecitabine, Temozolomide Drug
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 141 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2027
U.S. locations 446
States / cities Anchorage, Alaska • Fairbanks, Alaska • Gilbert, Arizona + 300 more About this Moffitt Cancer Center institution page
What this page lists ClinicalTrials.gov records that list Moffitt Cancer Center in Tampa, FL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .